Nanosensor dosimetry of mouse blood proteins after exposure to ionizing radiation

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Kim, Dokyoon ^a   Marchetti, Francesco ^e,f   Chen, Zuxiong ^a   Zaric, Sasa ^a   Wilson, Robert J ^a   Hall, Drew A ^a   Gaster, Richard S ^a   Lee, Jung Rok ^a   Wang, Junyi ^a   Osterfeld, Sebastian J ^b   Yu, Heng ^b   White, Robert M ^a   Blakely, William F ^c   Peterson, Leif E ^d   Bhatnagar, Sandhya ^e   Mannion, Brandon ^e   Tseng, Serena ^e   Roth, Kristen ^e   Coleman, Matthew ^e   Snijders, Antoine M ^e   Wyrobek, Andrew J ^e   Wang, Shan X ^a   more..

^a Stanford University   (United States)

^b MagArray Inc   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^f HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DIAGNOSTIC AGENT; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; PLASMA PROTEIN; SAA2 PROTEIN, MOUSE; SERUM AMYLOID A;

ANIMAL; ARTICLE; BLOOD; EQUIPMENT; FEMALE; GENETIC PROCEDURES; IONIZING RADIATION; MALE; MOUSE; NANOTECHNOLOGY; RADIATION RESPONSE; RADIOMETRY; REPRODUCIBILITY; STANDARD; TIME; DEVICES; DIAGNOSTIC USE; STANDARDS;

ANIMALS; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; BLOOD PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; MALE; MEMBRANE PROTEINS; MICE; NANOTECHNOLOGY; RADIATION, IONIZING; RADIOMETRY; REPRODUCIBILITY OF RESULTS; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 84880800169     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02234     Document Type: Article

References (49)

1. Brenner, D. J. et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl. Acad. Sci. USA 100, 13761-13766 (2003).
2. Atkinson, J. et al. A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death. Nat. Commun. 2, 497 (2011).
3. Blakely, W. F., Salter, C. A. & Prasanna, P. G. S. Early-response biological dosimetry - recommended countermeasure enhancements for mass-casualty radiological incidents and terrorism. Health Phys. 89, 494-504 (2004).
4. Pinto, M. M. P. de L., Santos, N. F. G. & Amaral, A. Current status of biodosimetry based on standard cytogenetic methods. Radiat. Environ. Biophys. 49, 567-581 (2010).
5. Fenech, M. Current status, new frontiers and challenges in radiation biodosimetry using cytogenic, transcriptomic and proteomic technologies. Radiat. Meas. 46, 737-741 (2011).
6. Budworth, H. et al. DNA repair and cell cycle biomarkers of radiation exposure and inflammation stress in human blood. PLoS One 7, e48619 (2012).
7. Rifai, N., Gillette, M. A. & Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983 (2006).
8. Li, J. et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat. Commun. 1, 34 (2010).
9. Dalton, W. S. & Friend, S. H. Cancer biomarkers - an invitation to the table. Science 312, 1165-1168 (2006).
10. Gosling, J. P. A decade of development in immunoassay methodology. Clin. Chem. 36, 1408-1427 (1990).
11. Rissin, D. M. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595-600 (2010).
12. Kingsmore, S. F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug. Discov. 5, 310-321 (2010).
13. Tabakman, S. M. et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat. Commun. 2, 466 (2011).
14. Cui, Y., Wei, Q., Park, H. & Lieber, C. M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293, 1289-1292 (2001).
15. Backmann, N. et al. A label-free immunosensor array using single-chain antibody fragments. Proc. Natl. Acad. Sci. USA 102, 14587-14592 (2005).
16. Stern, E. et al. Label-free biomarker detection from whole blood. Nat. Nanotechnol. 5, 138-142 (2010).
17. Cai, D. et al. A molecular-imprint nanosensor for ultrasensitive detection of proteins. Nat. Nanotechnol. 5, 597-601 (2010).
18. Fan, C., Plaxco, K. W. & Heeger, A. J. Electrochemical interrogation of conformational changes as a reagentless method for the sequence-specific detection of DNA. Proc. Natl. Acad. Sci. USA 100, 9134-9137 (2003).
19. Drummond, T. G., Hill, M. G. & Barton, J. K. Electrochemical DNA sensors. Nat. Biotechnol. 21, 1192-1199 (2003).
20. Gaster, R. S. et al.Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 15, 1327-1332 (2009).
21. Marchetti, F., Coleman, M. A., Jones, I. M. & Wyrobek, A. J. Candidate protein biodosimeters of human exposure to ionizing radiation. Int. J. Radiat. Biol. 82, 605-639 (2006).
22. Osterfeld, S. J. et al.Multiplex protein assays based on real-timemagnetic nanotag sensing. Proc. Natl. Acad. Sci. USA 105, 20637-20640 (2008).
23. Gaster, R. S., Hall, D. A. & Wang, S. X. Autoassembly protein arrays for analyzing antibody cross-reactivity. Nano. Lett. 11, 2579-2583 (2011).
24. Gaster, R. S. et al. Quantification of protein interactions and solution transport using high-density GMR sensor arrays. Nat. Nanotechnol. 6, 314-320 (2011).
25. Gaster, R. S., Hall, D. A. & Wang, S. X. nanoLAB: an ultraportable, handheld diagnostic laboratory for global health. Lab. Chip. 11, 950-956 (2011).
26. Ossetrova, N. I. & Blakely, W. F. Multiple blood-proteins approach for earlyresponse exposure assessment using an in vivo murine radiation model. Int. J. Radiat. Biol. 85, 83-850 (2009).
27. Blakely, W. F., Sandgren, D. J., Nagy, V., Kim, S.-Y. & Ossetrova, N. I. Murine partial-body radiation exposure model for biodosimetry studies - preliminary report. Radiat. Meas. 46, 898-902 (2011).
28. Lee, H.-J. et al. Identification of possible candidate biomarkers for local or whole body radiation exposure in C57BL/6 mice. Int. J. Radiat. Oncol. Biol. Phys. 69, 1272-1281 (2007).
29. Agrawal, D. K., Hopfenspirger, M. T., Chavez, J. & Talmadge, J. E. Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model. Int. Immunopharmacol. 1, 2081-2089 (2001).
30. Hannum, C. et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368, 643-648 (1994).
31. Prat, M. et al. Radiation-induced increase in plasma Flt3 ligand concentration in mice: evidence for the implication of several cell types. Radiat. Res. 163, 408-417 (2005).
32. Gratwohl, A. et al. FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood 92, 765-769 (1998).
33. Xu, Y., Yamada, T., Satoh, T. & Okuda, Y. Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA. Clin. Chem. Lab. Med. 44, 59-63 (2006).
34. Sung, H.-J. et al. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. J. Proteome. Res. 10, 1383-1395 (2011).
35. Kluve-Beckerman, B., Yamada, T., Hardwick, J., Liepnieks, J. J. & Benson, M. D. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2. Biochem. J. 322, 663-669 (1997).
36. Goltry, K. L., Epperly, M. W. & Greenberger, J. S. Induction of serum amyloid A inflammatory response genes in irradiated bone marrow cells. Radiat. Res. 149, 570-578 (1998).
37. Hall, D. A. et al. GMR biosensor arrays: a system perspective. Biosens. Bioelectron. 25, 2051-2057 (2010).
38. Hall, D. A. et al. GMR biosensor arrays: correction techniques for reproducibility and enhanced sensitivity. Biosens. Bioelectron. 25, 2177-2181 (2010).
39. Jonkheijm, P., Weinrich, D., Schröder, H., Niemeyer, C. M. & Waldmann, H. Chemical strategies for generating protein biochips. Angew. Chem. Int. Ed. Engl. 47, 9618-9647 (2008).
40. Goddard, J. M. & Erickson, D. Bioconjugation techniques for microfluidic biosensors. Anal. Bioanal. Chem. 394, 469-479 (2009).
41. Malan, A. K., Martins, T. B., Jaskowski, T. D., Hill, H. R. & Litwin, C. M. Comparison of two commercial enzyme-linked immunosorbent assays with an immunofluorescence assay for detection of legionella pneumophila types 1 to 6. J. Clin. Microbiol. 41, 3060-3063 (2003).
42. Gilbert, N. et al. Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J. Virol. Methods 100, 37-47 (2002).
43. Sproull, M., Avondoglio, D., Meushaw, T., Shankavaram, U. & Camphausen, K. Plasma Flt3-ligand as a biomarker for radiation exposure. Int. J. Radiat. Oncol. Biol. Phys. 78, S635 (2010).
44. Ossetrova, N. I., Sandgren, D. J., Gallego, S. & Blakely, W. F. Combined approach of hematological biomarkers and plasma protein SAA for improvement of radiation dose assessment triage in biodosimetry applications. Health Phys. 98, 204-208 (2010).
45. Kato, T. A. et al. Variations in radiosensitivity among individuals: a potential impact on risk assessment? Health Phys. 97, 470-480 (2009).
46. Tucker, S. L., Turesson, I. & Thames, H. D. Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 11, 1783-1791 (1992).
47. Schnarr, K., Dayes, I., Sathya, J. & Boreham. D. Individual radiosensitivity and its relevance to health physics. Dose-Response 5, 333-348 (2007).
48. Ossetrova, N. I., Farese, A. M.,MacVittie, T. J., Manglapus, G. L. & Blakely,W. F. The use of discriminant analysis for evaluation of early-response multiple biomarkers of radiation exposure using non-human primate 6-Gy whole-body radiation model. Radiat. Meas. 42, 1158-1163 (2007).
49. Hem, A., Smith, A. J. & Solber, P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab. Animals. 32, 364-368 (1998).